Publications supported by the COBRE on Opioids and Overdose must cite the grant number (P20GM125507) and, by law, be submitted to PubMed Central. Please review the NIH Public Access Policy.
Investigators who use COBRE services such as services from our Cores are also asked to acknowledge the grant in any resulting presentations or research publications.
Faculty who are supported by the COBRE on Opioids and Overdose must also acknowledge the grant in all research publications that are related to their role on the grant. Publications that are unrelated to the faculty member’s role with the COBRE may also acknowledge the grant. Although this is encouraged, it is up to the discretion of the researcher or faculty member.
How to acknowledge the COBRE on Opioids and Overdose:
Research conducted with direct support from the COBRE on Opioids and Overdose:
Research reported in this publication is supported by the National Institute of General Medical Sciences of the NIH under grant number P20GM125507. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Other research conducted by awardees and for faculty who are partially supported by the COBE on Opioids and Overdose:
[Insert Name] is partially supported by the National Institute of General Medical Sciences of the NIH under grant number P20GM125507. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
These guidelines reflect NIH Policy. Failure to comply with the terms and conditions of the Public Access Policy may result in the placement of special conditions on current awards or preclusion of grantees from obtaining future COBRE funding.
P20GM125507 Rich (PI)
09/01/18 – 08/31/23
Center of Biomedical Research Excellence (COBRE) on Opioids and Overdose
The goal of the COBRE on Opioids and Overdose is to establish the cores and researchers needed to develop and sustain a vibrant interdisciplinary center of research excellence on opioids and overdose.
The Center of Biomedical Research Excellence (COBRE) on Opioids and Overdose at Rhode Island Hospital is the first center of its kind to address the opioid epidemic. The Center is funded by a 5-year grant from the National Institute on General Medical Sciences and is directed by Principal Investigator Josiah “Jody” Rich, MD, MPH and Deputy Director Traci Green, PhD, MSc. The Center brings together an interdisciplinary team of researchers, policymakers, public health officials, community-based organizations, and scientists from across Rhode Island to help implement policies and practices that will curb this epidemic. The Center also aims to support excellence in research essential to understanding the mechanisms underlying opioid use disorder and developing innovative solutions.
The COBRE is organized into four cores, each led by experts in their fields from Brown University, Rhode Island Hospital and Miriam Hospital. The Administrative Core led by Dr. Jody Rich oversees the administrative structure and activities of the COBRE. The Data and Research Core led by Brandon Marshall, PhD provides quantitative expertise, methodological knowledge on study designs, and technological resources. The Translational and Transformative Core headed by Susan Ramsey, PhD and Traci Green, PhD, MSc strengthens translational research in social, behavioral, and clinical sciences, as well as improving study dissemination. Lastly, The Special Populations Core spearheaded by Curt Beckwith, MD and Timothy Flanigan, MD assists in the recruitment process and provide guidance in conducting ethical research with vulnerable populations.